Lyme on the brink – the battle for a vaccine June 13, 2014geeky science & health stuff, Homeantigens, bacterium, Baxter Healthcare, bioengineering, Borrelia burgdorferi, Brookhaven Institute, CDC, Centers for Disease Control, chimeric, class action lawsuit, deerticks, FDA, gene-splicing, GlaxoSmithKline, Ixodes scapularis, Lyme disease, LYMErix, multivalent, OspA, Pasteur Mérieux Connaught, Phase I trials, side effects, SmithKline Beecham, spirochete, Stony Brook University, vaccine By Ned White A Lyme vaccine for dogs, but not for us. Why not? What happened? And what’s happening now? There’s movement afoot, and significant progress, but we’ll still have to wait…